Publications by authors named "Ron Epelbaum"

Claim this Profile
M
Multisite Is Superior to Single-Site Intratumoral Chemotherapy to Retard the Outcomes of Pancreatic Ductal Adenocarcinoma in a Murine Model.
Janette Lazarovits, Ron Epelbaum, Jesse Lachter, Yaron Amikam, Jacob Ben Arie

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Older Adults With Rectal Cancer-Does Age Matter?: A Single-center Experience.
Katerina Shulman, Samar Musallam, Ron Epelbaum, Nissim Haim, Rahamim Ben-Yosef

Am J Clin Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring.
Ruth Perets, Orli Greenberg, Talia Shentzer, Valeria Semenisty, Ron Epelbaum

Oncologist· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious Mutation.
Rachna T Shroff, Andrew Hendifar, Robert R McWilliams, Ravit Geva, Ron Epelbaum

JCO Precis Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.
Eldad J Dann, Osnat Bairey, Rachel Bar-Shalom, Tanya Mashiach, Elinor Barzilai, Ron Epelbaum

Br J Haematol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer.
Talia Golan, Tal Sella, Eileen M O'Reilly, Matthew H G Katz, Ron Epelbaum

Br J Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
Simona Ben-Haim, Jenny Garkaby, Natalia Primashvili, Elinor Goshen, Ronnie Shapira, Ron Epelbaum

Nucl Med Commun· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Medical Use of Wheatgrass: Review of the Gap Between Basic and Clinical Applications.
Gil Bar-Sela, Miri Cohen, Eran Ben-Arye, Ron Epelbaum

Mini Rev Med Chem· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.
Ron Epelbaum, Einat Shacham-Shmueli, Baruch Klein, Abed Agbarya, Baruch Brenner

Biomed Res Int· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural products as potential cancer therapy enhancers: A preclinical update.
Abed Agbarya, Nili Ruimi, Ron Epelbaum, Eran Ben-Arye, Jamal Mahajna

SAGE Open Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Comment on: "Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT".
Antonia Dimitrakopoulou-Strauss, Alex Frenkel, Ron Epelbaum

J Nucl Med· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT.
Ron Epelbaum, Alex Frenkel, Riad Haddad, Natalia Sikorski, Ludwig G Strauss

J Nucl Med· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy and Quality Assessment of EUS-FNA: A Single-Center Large Cohort of Biopsies.
Benjamin Ephraim Bluen, Jesse Lachter, Iyad Khamaysi, Yassin Kamal, Leonid Malkin, Ron Epelbaum

Diagn Ther Endosc· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study.
Yavuz Anacak, Robert C Miller, Nikos Constantinou, Angela M Mamusa, Ron Epelbaum

Int J Radiat Oncol Biol Phys· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved.
Eldad J Dann, Zeev Blumenfeld, Rachel Bar-Shalom, Irit Avivi, Menachem Ben-Shachar, Ron Epelbaum

Am J Hematol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curcumin and gemcitabine in patients with advanced pancreatic cancer.
Ron Epelbaum, Moshe Schaffer, Bella Vizel, Vladimir Badmaev, Gil Bar-Sela

Nutr Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.
Eldad J Dann, Rachel Bar-Shalom, Ada Tamir, Ron Epelbaum, Irit Avivi

Haematologica· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.
Michal Weiler-Sagie, Olga Bushelev, Ron Epelbaum, Eldad J Dann, Nissim Haim

J Nucl Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG avidity and PET/CT patterns in primary gastric lymphoma.
Lea Radan, Doron Fischer, Rachel Bar-Shalom, Eldad J Dann, Ron Epelbaum

Eur J Nucl Med Mol Imaging· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study.
Wendy Jeanneret-Sozzi, Alphonse Taghian, Ron Epelbaum, Philip Poortmans, Daniel Zwahlen

BMC Cancer· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.
Zeev Blumenfeld, Irith Avivi, Ari Eckman, Ron Epelbaum, Jacob M Rowe

Fertil Steril· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Art therapy improved depression and influenced fatigue levels in cancer patients on chemotherapy.
Gil Bar-Sela, Lily Atid, Sara Danos, Naomi Gabay, Ron Epelbaum

Psychooncology· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome.
Eldad J Dann, Rachel Bar-Shalom, Ada Tamir, Nissim Haim, Menachem Ben-Shachar, Ron Epelbaum

Blood· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study.
Virginie Monnard, Alex Sun, Ron Epelbaum, Philip Poortmans, Robert C Miller

Int J Radiat Oncol Biol Phys· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma.
Eldad J Dann, Ron Epelbaum, Irit Avivi, Menachem Ben Shahar, Nissim Haim

Hum Reprod· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis